These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33795573)

  • 21. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
    Tallon B; Turnbull N
    Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
    Liebman TN; Stein JA; Polsky D
    J Am Acad Dermatol; 2013 Jan; 68(1):173-6. PubMed ID: 23244374
    [No Abstract]   [Full Text] [Related]  

  • 23. Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
    Nahm W; Nichols A; Rapoport E; Kirsner R; Badiavas E; Wyant W; Arthur A; Shen J
    J Drugs Dermatol; 2023 May; 22(5):486-490. PubMed ID: 37133482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
    Weinstock MA; Lee KC; Chren MM; Marcolivio K;
    J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
    Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the therapeutic results of actinic keratosis treated with topical 5% fluorouracil by reflectance confocal laser microscopy: preliminary study.
    Ishioka P; Maia M; Rodrigues SB; Marta AC; Hirata SH
    An Bras Dermatol; 2015; 90(3):426-9. PubMed ID: 26131881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
    Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
    Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
    Tee LY; Sultana R; Tam SYC; Oh CC
    J Am Acad Dermatol; 2021 Feb; 84(2):528-530. PubMed ID: 32387631
    [No Abstract]   [Full Text] [Related]  

  • 30. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
    Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
    Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.
    Nguyen BT; Gan SD; Konnikov N; Liang CA
    J Am Acad Dermatol; 2015 Mar; 72(3):558-60. PubMed ID: 25687314
    [No Abstract]   [Full Text] [Related]  

  • 32. Nicotinamide for Skin-Cancer Chemoprevention.
    Drago F; Ciccarese G; Parodi A
    N Engl J Med; 2016 Feb; 374(8):789-90. PubMed ID: 26933858
    [No Abstract]   [Full Text] [Related]  

  • 33. Nicotinamide for Skin-Cancer Chemoprevention.
    Zhao Y
    N Engl J Med; 2016 Feb; 374(8):789. PubMed ID: 26933857
    [No Abstract]   [Full Text] [Related]  

  • 34. Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Damian DL
    N Engl J Med; 2016 Feb; 374(8):790. PubMed ID: 26933856
    [No Abstract]   [Full Text] [Related]  

  • 35. Periocular actinic keratosis, keratinocyte carcinomas, and eyeglasses use.
    Lee KC; Weinstock MA;
    J Am Acad Dermatol; 2013 Jul; 69(1):165-7. PubMed ID: 23768294
    [No Abstract]   [Full Text] [Related]  

  • 36. Nicotinamide for skin cancer chemoprevention.
    Damian DL
    Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
    Han A; Penrose C; Goldsmith A; Marmur ES
    J Drugs Dermatol; 2010 Jul; 9(7):864-9. PubMed ID: 20677546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorouracil is Superior to Other Commonly Used Topical Agents for the Treatment of Field Cancerization.
    Ouchene L; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2019; 23(4):455-456. PubMed ID: 31337239
    [No Abstract]   [Full Text] [Related]  

  • 39. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
    Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
    Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective quality of life impact of actinic keratoses: observations from the veterans affairs topical tretinoin chemoprevention trial.
    Lee K; Weinstock M
    Acta Derm Venereol; 2011 Jan; 91(1):101-2. PubMed ID: 21103828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.